Growth Metrics

Avai Bio (AVAI) Income from Continuing Operations (2018 - 2025)

Avai Bio's Income from Continuing Operations history spans 6 years, with the latest figure at 3953518.0 for Q1 2024.

  • On a quarterly basis, Income from Continuing Operations fell 268.83% to 3953518.0 in Q1 2024 year-over-year; TTM through Mar 2024 was 5778561.0, a 581.5% decrease, with the full-year FY2025 number at 1142115.0, up 46.34% from a year prior.
  • Income from Continuing Operations hit 3953518.0 in Q1 2024 for Avai Bio, down from 1013900.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for AVAI hit a ceiling of 417163.0 in Q4 2020 and a floor of 3953518.0 in Q1 2024.
  • Historically, Income from Continuing Operations has averaged 559193.0 across 4 years, with a median of 225041.5 in 2020.
  • The widest YoY moves for Income from Continuing Operations: up 4203.92% in 2020, down 1770.01% in 2020.
  • Tracing AVAI's Income from Continuing Operations over 4 years: stood at 417163.0 in 2020, then plummeted by 73.52% to 110471.0 in 2022, then plummeted by 1017.8% to 1013900.0 in 2023, then tumbled by 289.93% to 3953518.0 in 2024.
  • Business Quant data shows Income from Continuing Operations for AVAI at 3953518.0 in Q1 2024, 1013900.0 in Q4 2023, and 399621.0 in Q3 2023.